By: Adam Feuerstein | 07/22/14 - 12:12 PM EDT
Survey: how high do $GILD's Sovaldi sales need to be tomorrow to move the stock up? — Meg Tirrell (@megtirrell) July 22, 2014To which I replied:
. @megtirrell There probably is no Sovaldi sales number high enough to prevent $GILD post-earning sell off. Short term trading… ZZZzzzzz — Adam Feuerstein (@adamfeuerstein) July 22, 2014The buyside "whisper number" for Sovaldi sales in the June quarter stands at $3.5 billion. But everyone who follows Gilead knows this, which means the "whispered" whisper number for sales of the blockbuster hepatitis C drug is probably more like $4 billion or more.
10/21/14 - 09:29 AM EDT
10/20/14 - 10:56 AM EDT
10/15/14 - 04:07 PM EDT
10/14/14 - 10:53 AM EDT
10/08/14 - 03:52 PM EDT
10/21/14 - 11:34 AM EDT
10/21/14 - 10:23 AM EDT
10/21/14 - 09:59 AM EDT
10/20/14 - 11:57 AM EDT
10/20/14 - 11:33 AM EDT
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.